Catherine Francisco

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 442 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, Alberto Papi, Massimo Corradi et al. · The Lancet · 2016 · 424 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study

Dave Singh, Aida Emirova, Catherine Francisco et al. · Respiratory Research · 2020 · 46 citations · Full text

Medicine, Clinical Sciences, Pharmacology +16

Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler®) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial

Frank Kanniess, Mario Scuri, Stefano Vezzoli et al. · Pulmonary Pharmacology & Therapeutics · 2014 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17